Literature DB >> 11869752

The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.

T Suppes1, G S Leverich, P E Keck, W A Nolen, K D Denicoff, L L Altshuler, S L McElroy, A J Rush, R Kupka, M A Frye, M Bickel, R M Post.   

Abstract

BACKGROUND: Since recent NIMH Bipolar Disorder Workshops highlighted the dearth of longitudinal and controlled studies of bipolar illness, the Stanley Foundation Bipolar Network (SFBN) has recruited a large cohort of patients with bipolar disorder to begin to address these issues. This report describes the demographics and course of illness characteristics of this study population.
METHODS: The first 261 outpatients to be diagnosed by the Structured Clinical Interview for DSM-IV (SCID) and complete a detailed patient and a brief clinician questionnaire are described. All patients met DSM-IV criteria for bipolar I (n=211), bipolar II (n=42), or NOS (n=5) or schizoaffective (n=3), bipolar type. Chi-square and t-tests were used to examine statistically significant associations among important demographic and descriptive items.
RESULTS: The general demographic and illness characteristics were similar to those in many bipolar clinical samples and not dissimilar from those reported in epidemiological surveys. The majority of patients had been hospitalized, with almost half reporting a worsening of illness over time, and two-thirds were not asymptomatic between episodes. First treatment for patients had been delayed by an average of 10 years from illness onset (by SCID). Almost a third of patients had attempted suicide at least once, and 30% reported current suicidal ideation at study entry. A total of 62% reported moderate to severe impact of the illness on occupational functioning. Early onset bipolar illness (< or =17 years old) was associated with increased frequency of mood switches, worsening course of illness, and history of early abuse (physical, verbal, or sexual).
CONCLUSION: The SFBN represents a sample of predominantly BP I patients largely recruited from the community who will be followed in detail longitudinally, participate in clinical trials, and thus help advance our understanding and treatment of this life-threatening medical disorder. While there is a broad range of illness characteristics and severity, the majority of patients have been severely impacted by their illness despite the availability of multiple conventional treatment approaches in the community. These data further underscore the need for development of new and earlier treatment interventions. LIMITATION: The SFBN population is limited by the lack of random selection and represents a cohort willing to be treated and followed intensively in academic tertiary referral centers. While its characteristics are similar to many clinical study populations, the generalizability to non-clinic populations remains uncertain.

Entities:  

Mesh:

Year:  2001        PMID: 11869752     DOI: 10.1016/s0165-0327(01)00432-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  89 in total

1.  Beyond psychopharmacology for bipolar disorder: psychotherapeutic interventions for the patient and family.

Authors:  Brenda J B Roman; Ann Morrison
Journal:  Psychiatry (Edgmont)       Date:  2004-07

2.  Efficacy and Safety of Once- versus Twice-Daily Carbamazepine Extended-Release Capsules for the Treatment of Manic Symptoms in Patients with Bipolar I Disorder.

Authors:  Richard H Weisler; Amir H Kalali; Andrew J Cutler; Thomas D Gazda; Lawrence Ginsberg
Journal:  Psychiatry (Edgmont)       Date:  2008-03

Review 3.  Functional impairment, stress, and psychosocial intervention in bipolar disorder.

Authors:  David J Miklowitz
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

4.  Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?

Authors:  Michael Bauer; Natalie Rasgon; Paul Grof; Laszlo Gyulai; Tasha Glenn; Peter C Whybrow
Journal:  MedGenMed       Date:  2005-08-25

5.  The relationship between brain volumes and intelligence in bipolar disorder.

Authors:  Annabel Vreeker; Lucija Abramovic; Marco P M Boks; Sanne Verkooijen; Annet H van Bergen; Roel A Ophoff; René S Kahn; Neeltje E M van Haren
Journal:  J Affect Disord       Date:  2017-07-06       Impact factor: 4.839

Review 6.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  Undiagnosed Bipolar Disorder: New Syndromes and New Treatments.

Authors:  Ira D Glick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

8.  Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Michael J Ostacher; Roy H Perlis; Andrew A Nierenberg; Joseph Calabrese; Jonathan P Stange; Ihsan Salloum; Roger D Weiss; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

9.  Clinical implications of cognitive function in bipolar disorder.

Authors:  C T Sudhir Kumar; Sophia Frangou
Journal:  Ther Adv Chronic Dis       Date:  2010-05       Impact factor: 5.091

10.  Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals.

Authors:  Gail H C Shen; Lauren B Alloy; Lyn Y Abramson; Louisa G Sylvia
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.